Assessment of diagnostic markers by goodness-of-fit testsNAKAS, Christos; YIANNOUTSOS, Constantin T; BOSCH, Ronald J et al.Statistics in medicine. 2003, Vol 22, Num 15, pp 2503-2513, issn 0277-6715, 11 p.Article

Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective StudyABRAHAM, Alison G; D'SOUZA, Gypsyamber; MOORE, Richard D et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 4, pp 405-413, issn 1525-4135, 9 p.Article

The impact of age on the prognostic capacity of CD8⁺ T-cell activation during suppressive antiretroviral therapyLOK, Judith J; HUNT, Peter W; COLLIER, Ann C et al.AIDS (London). 2013, Vol 27, Num 13, pp 2101-2110, issn 0269-9370, 10 p.Article

Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assaySTEWART, Paul; CACHAFEIRO, Ada; NAPRAVNIK, Sonia et al.Journal of clinical virology. 2010, Vol 49, Num 3, pp 198-204, issn 1386-6532, 7 p.Article

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatmentVOLBERDING, Paul; DEMETER, Lisa; BOSCH, Ronald J et al.AIDS (London). 2009, Vol 23, Num 15, pp 1987-1995, issn 0269-9370, 9 p.Article

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cellsARCHIN, Nancy M; ERON, Joseph J; COFFIN, John M et al.AIDS (London). 2008, Vol 22, Num 10, pp 1131-1135, issn 0269-9370, 5 p.Article

Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapyBOSCH, Ronald J; BENNETT, Kara; COLLIER, Ann C et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 3, pp 268-277, issn 1525-4135, 10 p.Article

Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitorsCLARK, Shauna A; SHULMAN, Nancy S; BOSCH, Ronald J et al.AIDS (London). 2006, Vol 20, Num 7, pp 981-984, issn 0269-9370, 4 p.Article

Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapyWEINBERG, Adriana; TIERNEY, Camlin; KENDALL, Michelle A et al.The Journal of infectious diseases. 2006, Vol 193, Num 4, pp 488-493, issn 0022-1899, 6 p.Article

Genetic correlates of efavirenz hypersusceptibilitySHULMAN, Nancy S; BOSCH, Ronald J; MELLORS, John W et al.AIDS (London). 2004, Vol 18, Num 13, pp 1781-1785, issn 0269-9370, 5 p.Article

Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12SHA, Beverly E; ONORATO, Michelle; BARTLETT, John A et al.AIDS (London). 2004, Vol 18, Num 8, pp 1203-1206, issn 0269-9370, 4 p.Article

MDR1 Gene polymorphisms and phase 1 viral decay during HIV-1 infection: An Adult AIDS Clinical Trials Group StudyHAAS, David W; HULIN WU; KESSLER, Harold et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, Num 3, pp 295-298, issn 1525-4135, 4 p.Article

Higher Expression of Several Interferon-Stimulated Genes in HIV-1-Infected Females After Adjusting for the Level of Viral ReplicationJUDY CHANG, J; WOODS, Matt; LINDSAY, Robert J et al.The Journal of infectious diseases. 2013, Vol 208, Num 5, pp 830-838, issn 0022-1899, 9 p.Article

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohortSMURZYNSKI, Marlene; KUNLING WU; LETENDRE, Scott et al.AIDS (London). 2011, Vol 25, Num 3, pp 357-365, issn 0269-9370, 9 p.Article

Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical TrialsTAYLOR, Lynn E; HOLUBAR, Marisa; KUNLING WU et al.Clinical infectious diseases. 2011, Vol 52, Num 6, pp 812-818, issn 1058-4838, 7 p.Article

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral TherapyBROWN, Todd T; SHIKUMA, Cecilia; TASSIOPOULOS, Katherine et al.Diabetes care. 2010, Vol 33, Num 10, pp 2244-2249, issn 0149-5992, 6 p.Article

Effect of vitamin supplements on HIV shedding in breast milkVILLAMOR, Eduardo; KOULINSKA, Irene N; ABOUD, Said et al.The American journal of clinical nutrition. 2010, Vol 92, Num 4, pp 881-886, issn 0002-9165, 6 p.Article

Prevalence of Primary Resistance at Baseline in Acutely and Recently Infected Subjects Enrolled in AIDS Clinical Trials Group Protocol 371DYKES, Carrie; MUKHERJEE, A. Lisa; BOSCH, Ronald J et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 1, pp 132-134, issn 1525-4135, 3 p.Article

Effect of Early versus Deferred Antiretroviral Therapy for HIV on SurvivalKITAHATA, Mari M; GANGE, Stephen J; ROURKE, Sean B et al.The New England journal of medicine. 2009, Vol 360, Num 18, pp 1815-1826, issn 0028-4793, 12 p.Article

A Trial of the Effect of Micronutrient Supplementation on Treatment Outcome, T Cell Counts, Morbidity, and Mortality in Adults with Pulmonary Tuberculosis. CommentaryBENN, Christine Stabell; FRIIS, Henrik; FAWZ, Wafaie W et al.The Journal of infectious diseases. 2008, Vol 197, Num 11, issn 0022-1899, 1499-1505, 1487-1489 [10 p.]Article

Maternal Disease Stage and Child Undernutrition in Relation to Mortality Among Children Born to HIV-Infected Women in Tanzania. CommentaryKUHN, Louise; THEA, Donald M; ALDROVANDI, Grace M et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 5, issn 1525-4135, 517-518, 599-606 [10 p.]Article

Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudineDYKES, Carrie; NAJJAR, Joe; BOSCH, Ronald J et al.The Journal of infectious diseases. 2004, Vol 189, Num 6, pp 1091-1096, issn 0022-1899, 6 p.Article

Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patientsWINTERS, Mark A; BOSCH, Ronald J; ALBRECHT, Mary A et al.The Journal of infectious diseases. 2003, Vol 188, Num 4, pp 537-540, issn 0022-1899, 4 p.Article

Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliterDEMETER, Lisa M; BOSCH, Ronald J; FISCHL, Margaret A et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 6, pp 2089-2094, issn 0095-1137Article

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infectionALBRECHT, Mary A; BOSCH, Ronald J; HAMMER, Scott M et al.The New England journal of medicine. 2001, Vol 345, Num 6, pp 398-407, issn 0028-4793Article